the vaccine, Dana–Farber Cancer Institute

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...
A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...
All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.
Lesley Jenkins had surgery to remove a tumour that was discovered following a routine bowel test.
Like infectious diseases, cancer will not observe a moratorium, and a halt in government vaccine research funding will ...
Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...
In a bid to tackle cervical cancer, one of the leading causes of cancer-related deaths among women, 500 adolescent girls from ...
A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...